Dietary Treatment of the Irritable Bowel Syndrome

Current Treatment Options in Gastroenterology
P J Whorwell, Richard Lea

Abstract

Most patients with functional gastrointestinal disorders report that food ingestion appears to exacerbate their symptoms and consequently conclude that they have some form of gastrointestinal food allergy or intolerance. Dietary management of functional gastrointestinal conditions is an attractive therapeutic option for the patient and physician alike because it is safe and economical and empowers the patient to help themselves. However, in practice, dietary manipulation frequently yields rather disappointing results. Exclusion diets can be helpful, but are labor intensive and occasionally can be very restrictive. Laboratory testing for immunoglobulin E food antibodies usually is not helpful, except in a small subgroup of patients with diarrhea, predominant irritable bowel syndrome (IBS), and atopy. There is some preliminary evidence to suggest that elimination diets based on immunoglobulin G food antibody testing may possibly have therapeutic potential in IBS, but this requires confirmation.

References

Aug 27, 1977·Lancet·A P ManningR F Harvey
Sep 11, 1975·The New England Journal of Medicine·R B LasserM D Levitt
Nov 1, 1992·Scandinavian Journal of Gastroenterology·P SymonsJ E Kellow
Sep 1, 1991·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·C LunardiM L Pacor
Jul 1, 1990·Journal of Pediatric Gastroenterology and Nutrition·E Barau, C Dupont
Oct 1, 1990·Gastroenterology·G F NelisW Jansen
Nov 4, 1989·BMJ : British Medical Journal·D G MaxtonP J Whorwell
Apr 1, 1985·Scandinavian Journal of Gastroenterology·S ArffmannE Krag
Dec 1, 1988·The American Journal of Clinical Nutrition·A S TruswellA W Thorburn
Oct 1, 1987·Journal of Clinical Gastroenterology·A M McKeeP J Whorwell
Feb 26, 1968·Annals of the New York Academy of Sciences·F R Steggerda
Aug 6, 1983·Lancet·S J BentleyK J Rix
Oct 1, 1994·Alimentary Pharmacology & Therapeutics·J Snook, H A Shepherd
May 7, 1994·Lancet·E YoungR Rona
Jul 2, 1994·Lancet·C Y Francis, P J Whorwell
Sep 1, 1993·Digestive Diseases and Sciences·A P WestonP B Miner
Feb 15, 1996·Annals of Internal Medicine·M D LevittS Olsson
May 1, 1996·Acta Paediatrica. Supplement·A Fasano
Dec 1, 1995·Alimentary Pharmacology & Therapeutics·F L SuarezM D Levitt
Mar 26, 1998·European Journal of Gastroenterology & Hepatology·M A Mendall, D Kumar
Apr 8, 1998·Nutrition·S J LewisA B Hawthorne
May 15, 1998·European Journal of Gastroenterology & Hepatology·S S RaoP Stumbo
Nov 20, 1998·The American Journal of Gastroenterology·A M NiecN J Talley
Aug 10, 2000·Alimentary Pharmacology & Therapeutics·M Di StefanoG R Corazza
Sep 30, 2000·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·M O'SullivanC A O'Morain
Nov 4, 2000·The American Journal of Medicine·J L JacksonK Kroenke
Jan 11, 2001·The American Journal of Gastroenterology·M PimentelH C Lin
Feb 24, 2001·Alimentary Pharmacology & Therapeutics·T PoynardY Benhamou
Jun 27, 2001·Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association·S Burden
Jul 18, 2001·PharmacoEconomics·R Lea, P J Whorwell

❮ Previous
Next ❯

Citations

Jan 20, 2006·La Revue du praticien·Benoît Coffin
Jun 30, 2009·Journal of the American Dietetic Association·William D HeizerSusan McGovern
May 23, 2007·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·X L ZuoP V Desmond
May 26, 2012·The American Journal of Medicine·Mary E Money, Michael Camilleri
Oct 26, 2005·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·M BelliniS Marchi
Oct 29, 2008·Journal of Pediatric Gastroenterology and Nutrition·Miguel Saps
Oct 13, 2005·Current Opinion in Gastroenterology·Marko A Kalliomäki
Apr 5, 2008·British Journal of Hospital Medicine·Gautam MehtaAndrew Thillainayagam

❮ Previous
Next ❯

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.